The Maze: Rossmann plans to launch an online pharmacy at the end of 2026. The storefront will sit inside the relationship Rossmann already owns: its shops, brand and app with more than 12 million active users. The regulated pharmacy itself will be a separate company in Emmen, Netherlands, serving German customers and accepting electronic prescriptions from statutory-insurance patients. This is retail distribution moving into healthcare—not a medicine tab quietly added to a webshop.
The app is Rossmann’s cheapest route into a costly market. Specialist online pharmacies normally have to buy attention, persuade users to install an app and then build repeat behavior. Rossmann starts with a mass-retail audience that already opens its app for offers and shopping. Pharmacy can add a higher-frequency, need-based reason to return. The 12 million figure is an acquisition funnel, not a customer forecast: Rossmann still has to convert users, earn trust around medicine and make the service useful enough to retain them.
Prescription demand changes the operating model. Germany’s electronic prescription, or E-Rezept, is digitally signed by a doctor and stored in a central health-system service. A customer can route it to an online pharmacy through an app, including by tapping an NFC-enabled health card against a phone via CardLink. Rossmann’s new unit therefore needs more than ecommerce checkout and parcel picking. Its pharmacists will check prescriptions, advise on interactions, handle medicine-safety issues and control regulatory quality before fulfilment.
The Dutch address is infrastructure, not a loophole. ROSSMANN-Apotheke B.V. will operate from Emmen, close to the German border, following a route already familiar in German mail-order pharmacy. The pharmacy can be Dutch while the demand is German, but German prescription rules and patient-service expectations still shape the offer. Rossmann has not disclosed delivery times, assortment size, pricing, partners or a precise launch date. Those gaps matter because medicine baskets punish slow stock visibility and service failures more severely than shampoo baskets.
Rossmann brings distribution strength into a specialist-led market. A SEMPORA model puts Redcare’s Shop Apotheke and the DocMorris group well ahead of smaller German online-pharmacy players in 2025. Rossmann’s edge is different: retail reach and an existing app audience. It is also taking the broader route from day one. Pharmacy-trade coverage contrasts its prescription ambition with dm-med’s current focus on over-the-counter products. That raises the upside—and the service burden.
Why it matters: Rossmann can turn loyalty-app distribution into a new regulated revenue stream, while prescription demand can make the app more useful and harder to delete. But this is not an easy margin extension. Management has already described the project as technically and legally complex and unlikely to pay back quickly. The real test is whether cheap access to millions of retail users offsets the cost of pharmacy expertise, compliant prescription handling, inventory availability and dependable delivery.
